FDA grants limited access to Zelnorm

07/27/2007 | Washington Post (tiered subscription model), The

Federal officials said some women can have access to Zelnorm, a drug for chronic constipation that was taken off the market in March. Women younger than 55 who have irritable bowel syndrome and chronic constipation and who have no known or pre-existing heart problems will have limited access.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID